Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty
Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
This is a randomized, double blinded, controlled trial in patients undergoing elective Total
Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA). The study group will receive
intra-articular Tranexamic Acid (TXA) while the control group will receive normal saline
placebo.